Matrix Laboratories Limited), one of the fastest growing pharmaceutical companies in India, is a publicly traded company based in Hyderabad, India. Matrix manufactures and supplies Active Pharmaceutical Ingredients (APIs) and intermediates, to research-based and generic pharmaceutical companies worldwide. The company is also engaged in Contract R&D for Drug Substance and Drug Product and Contract Manufacture of API and advanced intermediates for New Chemical Entities (NCEs).
Matrix has current sales of US $125 Million and 1600 employees (mainly scientists and technicians). 200 scientists are engaged in R&D alone, in the areas of Medicinal Chemistry, Synthetic Organic Chemistry, Process Development, Pharmaceutical Development and Analytical Sciences. Our cGMP manufacturing facilities have a total reactor capacity of 1000 m3 and are approved by the US-FDA, TGA (Australia), UK-MHRA and EDQM.
In the Generics segment of the business, Matrix offers non-infringing processes complying with international regulatory requirements, in all major therapeutic segments such as Anti-bacterials, CNS, Anti-Fungals, Anti-Virals, Anti-Retrovirals, Cardiovascular, Pain Management, Anti-Histamine and Anti-Asthmatics. We have commercialized over 50 products backed by DMF filings in Europe and North America. We have a robust pipeline under various stages of development targeting the Generics API market.
In the Contract Research and Development segment, we are able to rapidly provide pre-clinical and clinical-phase supplies along with route development, analytical methods and documentation to support regulatory filings. This group is focused on providing chemistry and Chemical Development support in all phases of Drug Development from Lead Optimization to Pre-Clinical Development into Commercial Manufacturing. Our project teams are focused on a customer's project and have a flat structure with a team leader providing a single point of contact for efficient communication.
The vision at Matrix Labs across all business segments is "To be an Innovative and Integrated Partner to the Global Pharmaceutical Industry". This complementary and service-oriented business model has won us long-term partnerships with many of our customers, who do not see us competing in their space.